Cargando…
Cas-Based Systems for RNA Editing in Gene Therapy of Monogenic Diseases: In Vitro and in Vivo Application and Translational Potential
Rare genetic diseases reduce quality of life and can significantly shorten the lifespan. There are few effective treatment options for these diseases, and existing therapeutic strategies often represent only supportive or palliative care. Therefore, designing genetic-engineering technologies for the...
Autores principales: | Reshetnikov, Vasiliy V., Chirinskaite, Angelina V., Sopova, Julia V., Ivanov, Roman A., Leonova, Elena I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245891/ https://www.ncbi.nlm.nih.gov/pubmed/35784464 http://dx.doi.org/10.3389/fcell.2022.903812 |
Ejemplares similares
-
Translational potential of base-editing tools for gene therapy of monogenic diseases
por: Reshetnikov, Vasiliy V., et al.
Publicado: (2022) -
New PAM Improves the Single-Base Specificity of crRNA-Guided LbCas12a Nuclease
por: Misiurina, Mariia A., et al.
Publicado: (2022) -
Methods for in vitro CRISPR/CasRx-Mediated RNA Editing
por: Chuang, Yu-Fan, et al.
Publicado: (2021) -
Characterization of Brevibacillus laterosporus Cas9 (BlatCas9) for Mammalian Genome Editing
por: Gao, Ning, et al.
Publicado: (2020) -
Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017)